CD80 and neoplasm: We postulated that in this tumor mouse model, PD-L1 co-inhibitory function would not be compromised by CD80 interaction in cis due to its weak expression, allowing PD-L1 freely to engage PD-1 inhibitory receptors that might be present on NK cells and modulate their functional responses.